The company's proprietary peptide-based intracellular delivery technology, known as the Feldan Shuttle, allows for the safe and efficient delivery of therapeutic proteins and peptides inside cells. This technology enables physicians to target intracellular components and deliver nucleases, transcription factors, and antibodies, unlocking the potential for advanced therapeutic applications. The Feldan Shuttle has been successfully used on various cell types, including human primary cells, which are crucial for cell-based therapeutic treatments.